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Smooth transformants which produce type VIII capsular polysaccharide have 
been  obtained  by  reciprocal  transformations  between  strains  VIILR1  and 
VIII-R13 of pneumococcus (1).  Both these  strains  are  R  (rough,  non-capsu- 
lated)  mutants of the S  (smooth, capsulated)  strain VIILS Henrique. 
When extracts of S strains of different capsular types were applied to VIII-R1 
or VIII-R13, S transformants of type VIII in many cases were detected in ad- 
dition to the expected S transformants of the same type as the donor strain.  In 
the  type VIII transformants  capsular  type was evidently determined  by the 
genome of the recipient  R  strain. 
The present  work was undertaken  to explore the possibility of producing S 
transformants  by reactions between pairs of R  mutants,  firstly from different 
S strains of the same type and secondly from S strains of different types, and 
also to search for more examples of the determination of type in S transformants 
by the genome of R  recipients. 
Materials and Methods 
Strains of Pneurnococcuz.--All the rough strains  used had been isolated  after cultivating 
S strains  in broth containing antiserum  of homologous type. II-Rat R, a  mutant of the S 
strain II-Rat, was isolated in 1947. II-R36, II-D39R19, II-D39MVR30, and II-RB are all R 
mutants of II-D39S that were isolated at different times. This paper reports  the first work 
carried out with II-RB, which was isolated in this laboratory in 1957 by Miss Jane Gutteron; 
the other mutants of II-D39S have been extensively studied in transformation  experiments 
(2, 3). VIII-R1 and VIII-R13 are mutants of VIII-S Henrique,  isolated in 1952 and 1949 
respectively  (1). Also used  were  transforming  extracts  made  from the  capsulated  strains 
I-SV1, II-D39S, III-A66S, VIII-S Henrique, XIV-S Eiders, and 1 strain  each of type VIIS 
and type XVIIIS. 
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and Infectious Diseases, United States Public Health Service. 
Fellow in Research  Medicine of the University  of Pennsylvania  on special leave  from 
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429 430  S TRANSFORM_ANTS ZFRO~ R  PNEUMOCOCCI 
Cultural Methods.--Beef  heart infusion broth containing 1 per cent neopeptone, pH  7.4 
to 7.5,  was used as the basis of all liquid media. For stock cultures 0.3 ml. of defibrinated 
normal rabbit blood was added  to a  tube containing 7  ml.  of broth. These cultures were 
stored at 5°C. for periods up to 1 month. Transformation trials and cultures grown for prep- 
aration of transforming extracts were inoculated from parent cultures grown in blood broth 
seeded from stock cultures. 
Nutrient blood agar was prepared by adding 5 per cent of citrated normal human blood 
to brain heart infusion agar supplied by the Baltimore Biological Laboratory, Baltimore. 
All cultures were incubated at 37°C. 
Preparation of  Transforming Extraas.mFor  each  preparation  of  transforming  extract, 
100 ml. of broth were inoculated with 0.3 ml. of a  7 hour blood broth culture, and incubated 
for 16 to 18 hours. Glucose solution was then added to a  concentration of 1 per cent, with 
0.1 ml. of phenol red (0.5 per cent in 95 per cent ethanol) as indicator, and incubation was 
continued. The tomato-red color imparted by the indicator was maintained by the addition 
of small amounts of 10 per cent sodium hydroxide solution at suitable intervals. When about 
3.5 ml. of sodium hydroxide solution had been added  (usually after about 6 hours), samples 
of the culture were removed for testing as described below, and 3 gm. of sodium citrate dis- 
solved in 10 ml. water were added. The resultant citrate concentration of 0.1 x¢ is inhibitory 
to  the  destruction of  transforming principle by desoxyribonuclease in  the  crude bacterial 
lysate  (4).  Sodium desoxycholate solution was  then added  to  a  concentration of 0.05  per 
cent; lysis of the cells rapidly ensued. 
Within 30 minutes 1 volume of ethanol was added to the lysed culture and the mixture 
was  manually shaken.  The white,  fibrous precipitate  which appeared  was  sedimented by 
briefly centrifuging at 850 g, and the supernatant liquid was discarded. The precipitate was 
dissolved in 10 ml. of 0.1  ~  sodium chloride solution, and protein was removed by shaking 
for 15 minutes with 2 successive lots of 2 ml. of chloroform plus 0.1 ml. of octanol. The chloro- 
form layer was discarded after being separated by centrifuging for 5 minutes at 1,100 g. The 
aqueous phase was transferred to a  sterile tube and after reprecipitation with I  volume of 
ethanol, the transforming extract was stored at 5°C. Before use the precipitate was sedimented 
by briefly centrifuging at 1,100 g, the supernate was discarded and the precipitate was redis- 
solved in 10 ml. of sterile 0.1 ~t sodium chloride solution. 
It was important to prove that S cultures at the time of lysis were free from R  mutants 
and,  more important, that R  cultures were free from S mutants. In the case of capsulated 
strains, homogeneity was tested by streaking a  loopful of culture on blood agar, incubating 
overnight and examining the colonies formed. These were invariably found to be a homogene- 
ous, smooth population and to give a queUung  reaction with the appropriate type antiserum. 
R  strains were similarly tested, and a homogeneous, rough population was invariably found. 
This test was not considered to be sufficiently rigorous and an additional test was run in 
parallel. A  loopful of culture was inoculated into 2 ml. of 10 per cent human serum broth, 
which agglutinates R  organisms and gives scope for the multiplication of S organisms in the 
superuate; after incubating overnight, a loopful of the supernate was streaked on blood agar 
and incubated for 18 hours; smooth colonies were never found. 
Transformation Reactions.--Serum factors which consist presumably of albumin and anti- 
R  aggiutinins (2, 5) were supplied in the form of normal human serum prepared by heating 
citrated normal human plasma at 60  ° for 30 minutes, centrifuging for 1 hour at 850 g, and 
discarding the precipitate. The plasma was prepared from recently outdated blood from a 
blood bank. 
In a typical experiment, 40 ml. of 10 per cent human serum broth was inoculated with 0.2 
ml. of a  lO0-fold dilution of a blood broth culture of the recipient strain that had been stored 
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of  11  mm.  internal diameter. Three control tubes received no  extract.  Five transforming 
extracts were tested, each in 3  tubes, by adding an aliquot of 0.1  ml.  of extract solution. 
Experience with numerous pneumococcal extracts has shown that this amount is in excess 
of that required for the maximum rate of transformation. The tubes were incubated for 17 
to 19 hours, after which most of the untransformed R  organisms had been agglutinated and 
had sedimented to the bottom. A loopful of the supernate was streaked on blood agar. The 
rest of the supernate was carefully pipetted off for further testing; it was stored at 5°C. after 
adding a drop of defibrinated rabbit blood. After incubating for 24 hours the streak on blood 
agar was examined for the presence of smooth colonies. In many cases, even when the super- 
nate of the transformation tube was not detectably turbid, as well as in all cases in which 
turbidity was present, many smooth colonies  were observed. (It must be pointed out that 
the operation of selection pressures makes the number of S colonies  an uncertain index of 
transformation frequency; the method as used was not intended for the precise measurement 
of transformation frequencies.) If no smooth colonies were found in the first streak on blood 
agar, 0.S ml. of supernate from the transformation tubes was added to 2 ml. of 10 per cent 
human serum broth to give a still better opportunity for the growth of any S transformants. 
Control tubes to which extract had not been added were always examined in the same way. 
When S colonies were found in  the  streaks from  the culture  supernate type specificity of 
the pneumococci was determined by qudlung reaction. When the reacting strains came from 
different types, S transformants were  tested  for quellung reactions  with antisera  of both 
types. Occasionally,  colonies  of both  types were found  in  the same streak, but in  no  case 
did any individual colony react  with antisera of both  types. When only  1 of the  possible 
transformant types was found, the other type was  searched  for  by  cultivating 0.2  mi.  of 
the original superuate in 2 mi. of broth containing 10 per cent of antiserum of the type al- 
ready found in  order to  select  against it;  the  supernate of  this  culture  was  streaked on 
blood agar, and any smooth colonies  found were tested for quellung reactions. This tech- 
nique often revealed transformants of the second type. 
EXPERIMENTAL 
Controls in Transformation Experiments.--A  total  of  362  control  tubes  to 
which transforming extract had not been added were included in a total of 119 
experiments. In only 3 tubes, each in a different experiment, were S organisms 
found; in 2  instances,  the strain in question was  II-RB;  in the third,  it was 
VIII-R1.  S organisms found in tubes containing transforming extract in these 
experiments were not regarded as transformants. 
In 6 tubes containing transforming extracts in 2 different experiments and also 
in  1  control  tube in  1  of  these  experiments,  organisms  of  strain  II-D39R19 
failed to agglutinate in 10 per cent human serum broth. The colonial morphol- 
ogy appeared to be normally rough, but there was evidently a trace of type II 
polysaccharide produced since an agglutinated disc was formed when a loopful 
of the turbid culture was inoculated into 2 ml.  of  10 per cent type II serum 
broth and incubated overnight. The status of these organisms as transformants 
was considered doubtful, and they were not counted as such. 
These results are considered to provide a sound guarantee for the transforma- 
tion results reported below. 
Transformations to Type IIS between Pairs of IIR Strains of Pneumococcus.-- 
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each of the other 4, and the cultures were examined for the presence of capsu- 
lated transformants. 
Type IIS transformants were found in 9 of the 20 trials (Table I), the 5 nega- 
tive results in trials of a strain tested against its own extract being discounted. 
Of the 11 negative results, 8 involved the strain II-R36, which was entirely in- 
active both as a recipient and as a donor. All the other strains were active in at 
least 1 instance both as donors and recipients. Transformants were obtained 
from all  pairings except the pairing between II-D39R19 and II-D39MVR30. 
Reciprocal  transformations  occurred in all  the other pairings  except II-Rat 
R  with II-RB;  II-Rat  R  transformed II-RB,  but  was  not  transformed by 
II-RB extract. 
TABLE  I 
IIS Transformants Found after Exposing Cells of 1117, Strains of 
Pneumococcus to Extracts of Other IIR Strains 
Recipient strain 
II-Rat R ............. 
II-RB ................ 
II-D39R19  ............ 
II-D39MVR30 ........ 
II-R36 ............... 
Donor strain from which transforming extract was prepared 
II-Rat R 
o 
+  (6/6) 
+  (4/6) 
+  (2/9) 
0 
II-RB 
o 
o 
+  (2/9) 
+  (1/12) 
o 
II-D39RI9 
+  (2/6) 
+  (6/6) 
0 
0 
0 
II-D39MVR30 ! 
+  (3/6) 
+  (6/9) 
0 
0 
0 
II-R35 
The symbol (+) signifies that S transformants were found. The denominator of the frac- 
tion in brackets is the total number of tubes in which tests were made;the numerator is the 
number of these tubes in which S transformants were found. 
All S transformants were proved by qu~lung reactions to be of type II. 
The symbol 0  signifies that no transformants were found; for each trial, not less than 3 
tubes were tested in each of 3  experiments. 
It is notable that transformants of II-D39MVR30 were found in 3 tubes only. 
This is in line with the poor receptivity of this strain with extracts of capsulated 
strains (Table IV). More surprising was the low activity of II-RB extract with 
IIR recipients  especially since  this  extract readily transformed VIII-R1  to 
VIIIS (Table II). The absence of II-R36 transformants is presumably not due 
to poor receptivity, since the strain is readily transformable by extracts of cap- 
sulated strains (Table IV). 
Transformations  between  IIR  and  VIIIR  Strains  of  Pneumococcus.--The 
strains VIII-R1 and VIII-R13 were tested as donors and recipients in transfor- 
mation reactions with the 5 IIR strains (Tables II and III). 
As in trials among the IIR strains, no transformations were found with II-R36 
either as donor or as recipient. Type VIIIS transformants were found when each 
of the other IIR extracts was applied to VIII-R1 cells (Table II) or, with the S.  ]'ACKSON~  C.  M.  MACLEOD,  AND  M'.  R.  K-RAUSS  433 
TABLE II 
Transformants  Found in Reactions  between fIR Strains 
and Strain  VIII-R1 of Pneuraococcus 
IIR strain 
II-Rat R .............. 
II-RB ................ 
II-D39R19 ............ 
II-D39MVR30 ......... 
II-R36 ................ 
VIII-R1 as donor strain  VIII-RI  as recipient strain 
VIIIS  IIS 
+  (2/9) 
+  (7/12) 
+  (1/9) 
0 
0 
o 
+  (7/11) 
o 
o 
o 
VIHS  IIS 
+  (1s/is)  o 
+  (12/12)  0 
+  (1s/is)  o 
+  (Is/Is)  o 
o  o 
For each thai, not less than 3  tubes were tested in each of 3 experiments. 
The symbol (+)  sign/ties that S  transformants of the specified type were found. The de- 
nominator of the fraction in brackets is the total number of tubes in which tests were made; 
the numerator is the number of these tubes in which S  transformants of the specified type 
were found. 
The symbol 0 signifies that no transformants were found. 
TABLE HI 
Transformants Found in Reactions  between IIR Strains 
and Strain VIII-R13 o/Pneuraococcus 
IIR strain 
II-Rat R .............. 
II-RB ................ 
II-D39R19 ............ 
II-D39MVR30 ......... 
II-R36 ................ 
VIII-RI3  as donor strain  VIII-R13 as recipient  strain 
VIIIS  IIS 
o 
+  (5/9) 
0 
0 
0 
o 
+  (8/9) 
o 
o 
o 
VIIIS  IIS 
+  (3/9)  0 
0  0 
+  (4/12)  o 
-4-  (2/12)  0 
o  o 
For each trial not less than 3 tubes were tested in each of 3 experiments. 
The symbol (+)  signifies that S  transformants of the specified type were found. The de- 
nominator of the fraction in brackets is the total number of tubes in which tests were made; 
the numerator is the number of these tubes in which S  transformants of the specified type 
were found. 
The symbol 0  signifies that no transformants were found. 
exception of II-RB extract, when applied to VIII-R13 (Table III). Type VIIIS 
transformants were also found when VIII-R1 extract was tested with II-Rat R 
and II-D39R19 as recipients. 
The most striking feature of these observations is that type IIS transform- 
ants, in addition to those of type VIIIS, were found when extracts of VIII-R1 
and VIII-R13 were applied to II-RB; progeny of 2 different capsular types arose 
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Comment has already been made on the poor receptivity of strain II-D39- 
MVR30. Strain VIII-R13 showed equally poor recipient activity. 
Transformations  of IIR Strains of Pneumococcus  by Extracts of S  Strains of 
Various Capsular Types.--The 5 IIR strains were exposed to transforming ex- 
tracts of S strains of types I, II, III, VII, VIII, XlV, and XVIII. Transform- 
ants of donor type were found  in most trials,  including  those  with II-R36 as 
recipient for all donor types except VIIS (Table IV). This contrasts with  the 
TABLE IV 
S Transformants Found after Exposing IIR Strains of Pnoumococcus to 
Extracts of S Strains of Different Pneumococcal Types 
Capsular type of donor  strain from which transforming extract was prepared 
Recipient strain 
IS  VIIS  "IIIS  XVIIIS 
II-RatR  D 
d 
II-RB  D 
d 
II 
II-D39R19 
II-D39MVR30 
II-R36  D 
d 
(4110) 
(8/lO) 
(2112) 
(6112) 
(1112) 
(1/9) 
0 
(0/8) 
(4/9) 
(~/9) 
IIS 
D  =  II 
(616) 
D  =  II 
(6/6) 
D  =  II 
(6/6) 
D  ~  II 
(4/6) 
D= II 
(316) 
IIIS 
D  (919) 
D  121121) 
D  19/9) 
D  :319) 
D  9/9) 
D  (8/9) 
II (s/9) 
D  (219) 
II (9/9) 
Ii (119) 
0 
(019) 
0 
(O/9) 
D  (11/15) 
D  (13/is) 
ii (15/15) 
D  (9/9) 
II  (5/9) 
D  (6/12) 
IX  (4/12) 
D  (819) 
XIVS 
D  (9/10) 
D  (14/16) 
II  (2/9) 
0 
(0/s) 
D  (519) 
D  (10/10) 
II  (1/10) 
D  (7/9) 
II  (8/9) 
D  (6/12) 
II  (2/12) 
0 
(0/9) 
D  (7/9) 
The symbol D signifies that fully encapsulated tremdormants of the same type as the donor strain were found; 
the symbol d signifies that transformants producing only a  small amount of donor-type polysaccharide were 
found. 
The symbol II signifies that transformants of type II were found. 
The denominator of the fraction in brackets is the total number of tubes in which tests were  made; the numera- 
tor is the number of these tubes in which the specified transformants were found.  The figures for type II trans- 
formants found after applying type XVIII extract are minimal; no type XVIII serum was available for selecting 
against the type XVIII transformants which tended to predominate. 
The symbol 0 signifies that no transformants were found. 
inactivity of II-R36 with other IIR strains and with VIIIR strains. IIS trans- 
formants of  II-R36 were never found except with  IIS extract. On  the  other 
hand  each  of  the  other IIR strains  gave IIS  transformants with at  least  1 
extract of heterologous S type. 
Each of the S extracts, with the important exception of IIIS, transformed at 
least 1 of the IIR strains to IIS. 
The poor receptivity of II-D39MVR30 may be held responsible for its failure 
to transform with some extracts,  and this is probably also the case with II- 
D39R19. 
In addition to fully capsulated transformants of type I, transformants pro- S.  JACKSON~ C.  M.  MACLEOD~ AND M.  R.  K1LAUSS  435 
ducing a  smaller amount of type I  polysaccharide were often found after ex- 
posing IIR cells to IS extract. Although the morphology of these partially cap- 
sulated transformants was similar to that of the IIR recipients, they were not 
agglutinated by anti-R serum. The presence of type I polysaccharide could not 
be demonstrated by quellung reaction, but was made evident by the formation 
of an agglutinated disc after a single colony from a blood agar plate was inocu- 
lated into 10 per cent type I serum broth and incubated overnight. 
DISCUSSION" 
The reciprocal transformations to IIS between strains II-RB and II-D39R19 
and between ILRB and II-D39MVR30, all of which are R mutants of the same 
S strain II-D39S, constitute a parallel case to the reciprocal transformations to 
VIIIS between VIILR1 and VIII-R13 (1). Further, the reciprocal transforma- 
tions to IIS between II-Rat R and II-D39R19 or II-D39MVR30 and the trans- 
formation of ILRB to IIS by II-Rat R  provide examples of capsular transfor- 
mation between R  mutants of different S strains of the same type. Evidently 
II-Rat R, II-RB, and II-D39R19 are non-identical mutants of IIS. It seems 
possible that  II-D39R19 and II-D39MVR30  are identical mutants  as far as 
capsulation is concerned. 
The experiments reported do not permit a  decision as to whether the non- 
identical mutations are concerned with different functions involved in capsular 
synthesis or whether they are mutations at different sites in a single gene locus 
affecting only 1 function (5). In this connection, Smith and Mills (7) have ex- 
amined strains  VIII-R1  and VIII-R13  for possible biochemical blocks along 
the path of synthesis of uridine diphosphate glucuronic acid (UDPGA),  I which 
is presumed to be an essential intermediate in the synthesis of capsular poly- 
saccharides  which  contain glucuronic acid residues  (8).  Both strains yielded 
enzyme extracts which catalyse the reactions: 
uridine triphosphate q- glucose-l-phosphate  -~ 
uridine diphosphate glucose --~ 
uridine diphosphate glucuronic  acid 
Large amounts of UDPGA are synthesised by cells of both strains, and their 
failure to form capsules of type VIII polysaccharide is probably due to defi- 
ciency at a later stage of its synthesis. In this case also, whether the non-identi- 
cal mutations are at different sites of the same locus or in different loci remains 
unknown. 
The capsular  transformations between IIR and  VIIIR  strains  (Tables II 
and III) are relevant to the question of genetic determination of capsular type. 
It has been postulated that the synthesis of pneumococcal capsular polysac- 
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charides of different types is dependent on structural determination by tem- 
plates under the control of single allelomorphic genes (see review by Wilkinson 
(9)). The transformation of II-RB to IIS by VIII-R1 (Table II) and VIII-R13 
(Table III) seems difficult to account for on this hypothesis, since it appears 
that II-RB fails to synthesise type II polysaccharide because of mutational de- 
ficiency which can be made good by VIII-R1 and VIII-R13. An alternative hy- 
pothesis is that the structure of capsular polysaccharide is determined by the 
action of a number of enzymes, each controlled by a different gene. On this basis 
it would be more reasonable that VIII-R1 and VIII-R13 should possess intact a 
gene which has mutated in II-RB. It seems likely that some of the same en- 
zymes are involved in the synthesis of different type-specific polysaccharides, 
even at stages subsequent to the synthesis of UDPGA, but the possession of 
the same gene by different types need not require that the gene be biochemicaUy 
active in all types. 
It is clear that R strains in general are not blank sheets on which capsule pro- 
duction is imposed solely by the genome of S donor strains. The determination 
of capsular type by an R  donor in the transformations to VIIIS of II-Rat R, 
II-RB  and II-D39R19 by extracts of VIII-R1, and of II-RB by extracts of 
VIII-R13, are very striking illustrations of this fact. Table IV contains numer- 
ous examples of the determination of capsular type by R  recipients. Mention 
has already been made of the similar results reported for VIIIR recipients (1). 
Strain II-R36 is unusual in that it never gave rise to IIS transformants either 
as a donor or as a recipient except when IIS extract was applied to it. It appears 
that II-R36 has multiple genetic deficiencies  affecting the synthesis of type II 
polysaccharide, possibly in the form of a  deletion. 
Transforraants of type IIS were never found when extract of III-A66S was 
applied to IIR strains, which suggests that III-A66S may be deficient in a way 
comparable with II-R36 in the genetic requirements for synthesis of the heter- 
ologous type II polysaccharide. 
MacLeod and Krauss (1)  found VIIIS transformants of VIII-R1  with ex- 
tracts of S strains of capsular types I, II, VII, VIII, XIV, and XVIII, but not 
with extract of IIIS. The unique distinction of giving neither IIS transformants 
with IIR recipients, nor of VIIIS when applied to VIIIR belongs to IIIS. On 
the hypothesis that a number of enzymes, each under separate genetic control, 
is involved in the synthesis of each type-specific polysaccharide, it appears that 
all the S types tested except IIIS possess  a gene which is concerned with syn- 
thesis of VIIIS polysaccharide, and a  gene which is concerned with synthesis 
of IIS polysaccharide. Genetic evidence of this nature should be valuable in 
pointing the way for biochemical investigation of the pathways leading to the 
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SUMMARY 
Capsulated transformants producing type II polysaccharide have been ob- 
tained by reactions between a number of R  mutants of type II pneumococcus. 
All the IIR strains except II-R36 yielded extracts which transformed 2 VIIIR 
strains to VIIIS. Two of the IIR strains were transformed to VIIIS by an ex- 
tract of 1 VIIIR strain. 
The most striking result was the production of both IIS and VIIIS transform- 
ants by the action of extracts of both VIIIR strains applied to cells of II-RB. 
This suggests that the determination of capsular type in pneumococcus does 
not depend on single allelomorphic genes; it seems more likely that a number of 
genes may be required to determine type specificity, and that some genes may 
be common to different types, possibly in connection with common biochemical 
pathways for some stages of polysaccharide synthesis. 
This is further indicated by the finding that extracts of capsulated strains of 
each of the types I, II, nI, vii, VIII, XIV, and XVIII are capable of giving 
ns  transformants with 1 or more of the IIR strains in addition to the expected 
donor-type transformants. 
Strain II-R36 was transformed by extracts of all S types except type VII, 
but the only transformants found were of the donor type. It appears that II-R36 
may have multiple genetic deficiencies for type n  capsulation, possibly in the 
form of a deletion. This may be the case also with InS strains since only IIIS 
transformants were found when InS  extract was applied  to any of the nR 
strains. 
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